Evidence-Based Complementary and Alternative Medicine / 2012 / Article / Tab 1

Research Article

Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial

Table 1

Demographics of patients in each group.

Experimental group ( )Control group ( ) -value

(1) age (year)
mean (SD)51.3 (9.8)53.2 (8.7)

(2) Body mass index (kg/m2)
mean (SD)22.9 (3.8)23.2 (3.5)

(3) Menopausal status n (%)
Pre-menopause10 (40.0%)12 (52.1%)
Post-menopause15 (60.0%)11 (47.9%)

(4) Clinical  stage (%)
Stage I8 (32.0%)7 (30.4%)
Stage II10 (40.0%)9 (39.2%)
Stage IIIA7 (28.0%)7 (30.4%)

(5) Treatment (%)
Surgery + endocrine therapy4 (16.0%)3 (13.1%)
Surgery + radiation + endocrine therapy4 (16.0%)4 (17.3%)
Surgery + chemotherapy + endocrine
Therapy11 (44.0%)10 (43.5%)
Surgery + chemotherapy + radiation + endocrine therapy6 (24.0%)6 (26.1%)

(6) Duration of endocrine therapy (%)
>6 Months to 3 years15 (60.0%)13 (56.5%)
>3 years to 5 years10 (40.0%)10 (43.5%)

(7) Physical Activity (%)
2 (8.0%)1 (4.3%)
7 (28.0%)10 (43.5%)
12 (48.0%)9 (39.1%)
4 (16.0%)3 (13.1%)

 (8) Diet (%)
03 (12.0%)2 (8.6%)
1~27 (28.0%)6 (26.1%)
3~48 (32.0%)9 (39. 2%)
57 (28.0%)6 (26.1%)